Advanced Medical Solutions Group (LON:AMS) Stock Price Passes Above 200 Day Moving Average – Here’s Why

Advanced Medical Solutions Group plc (LON:AMS) shares passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 207.19 and traded as high as GBX 216.50. Advanced Medical Solutions Group shares last traded at GBX 213.50, with a volume of 2,559,054 shares changing hands.

Analyst Upgrades and Downgrades

AMS has been the subject of a number of research analyst reports. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a GBX 275 price target on shares of Advanced Medical Solutions Group in a report on Wednesday, July 16th. Berenberg Bank restated a “buy” rating and issued a GBX 300 price objective on shares of Advanced Medical Solutions Group in a research note on Wednesday, September 17th. Finally, Peel Hunt reiterated a “buy” rating and set a GBX 246 target price on shares of Advanced Medical Solutions Group in a research note on Wednesday, September 17th. Three investment analysts have rated the stock with a Buy rating, According to MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of GBX 273.67.

Advanced Medical Solutions Group Stock Performance

The company has a quick ratio of 4.58, a current ratio of 8.39 and a debt-to-equity ratio of 37.01. The firm has a 50-day moving average of GBX 216.35 and a 200 day moving average of GBX 207.56. The stock has a market capitalization of £457.16 million, a P/E ratio of 50.69, a PEG ratio of 5.00 and a beta of 0.74.

Advanced Medical Solutions Group (LON:AMS) last announced its quarterly earnings results on Wednesday, September 17th. The company reported GBX 5.77 earnings per share (EPS) for the quarter. Advanced Medical Solutions Group had a net margin of 8.49% and a return on equity of 4.57%. Research analysts anticipate that Advanced Medical Solutions Group plc will post 9.8159509 EPS for the current fiscal year.

Insider Activity

In other Advanced Medical Solutions Group news, insider Eddie Johnson sold 18,726 shares of Advanced Medical Solutions Group stock in a transaction that occurred on Monday, October 6th. The stock was sold at an average price of GBX 220, for a total transaction of £41,197.20. Also, insider A Christopher (Chris) Meredith sold 50,510 shares of the company’s stock in a transaction that occurred on Wednesday, September 24th. The shares were sold at an average price of GBX 218, for a total value of £110,111.80. Corporate insiders own 4.12% of the company’s stock.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.